¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"calcium disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • oppositional defiant disorder
    ¸Â¼¶¹ÝÇ×Àå¾Ö, Àû´ëÀû¹ÝÇ×Àå¾Ö
  • organic mental disorder
    ±âÁúÁ¤½ÅÀå¾Ö, ±âÁúÁ¤½Åº´
  • organic personality disorder
    ±âÁúÀΰÝÀå¾Ö
  • overanxious disorder
    °ú´ÙºÒ¾ÈÀå¾Ö
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • phonological disorder
    À½¼ºÇÐÀûÀå¾Ö, À½¿îÀå¾Ö
  • panic disorder
    °øÈ²Àå¾Ö
  • postpartum mood disorder
    ºÐ¸¸ÈıâºÐÀå¾Ö
  • premenstrual dysphoric disorder
    ¿ù°æÀüºÒÄèÀå¾Ö
  • psychogenic disorder
    Á¤½Å¼ºÀå¾Ö
  • psychogenic pain disorder
    Á¤½Å¼ºÅëÁõÀå¾Ö
  • psychogenic voice disorder
    Á¤½Å¼ºÀ½¼ºÀå¾Ö
  • psychophysiologic disorder
    Á¤½Å»ý¸®Áúȯ
  • psychosexual disorder
    Á¤½Å¼º¼ºÀûÀå¾Ö
  • psychosomatic disorder
    Á¤½Å½ÅüÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • pervasive developmental disorder
    Àü¹Ý¹ß´ÞÀå¾Ö
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • phonological disorder
    À½¼ºÇÐÀûÀå¾Ö
  • physiological disorder
    »ý¸®ÀûÀå¾Ö
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • postejaculatory pain disorder
    »çÁ¤ÈÄÅëÁõÀå¾Ö, »çÁ¤ÈÄÅëÁõº´
  • postpartum mood disorder
    »êÈıâºÐÀå¾Ö, »êÈıâºÐº´
  • premenstrual dysphoric disorder
    ¿ù°æÀüºÒÄèÀå¾Ö, ¿ù°æÀüºÒÄ躴
  • pseudounipolar disorder
    °ÅÁþȬ±ØÀå¾Ö, °ÅÁþȬ±Øº´
  • psychiatric disorder
    Á¤½Å°úÁúȯ
  • psychogenic disorder
    Á¤½Å¼ºÀå¾Ö, Á¤½ÅÅ¿Àå¾Ö
  • psychogenic pain disorder
    Á¤½Å¼ºÅëÁõÀå¾Ö, Á¤½Å¼ºÅëÁõº´, Á¤½ÅÅ¿ÅëÁõÀå¾Ö
  • psychogenic voice disorder
    Á¤½Å¼ºÀ½¼ºÀå¾Ö
  • psychophysiologic disorder
    (¢¡psychosomatic disorder) Á¤½Å½Åüº´
  • psychosomatic disorder
    Á¤½Å½Åüº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • depressive personality disorder
    ¿ì¿ï¼ºÀΰÝÀå¾Ö(éØê¦àõìÑÌ«î¡äô)
  • developmental arithmetic disorder
    ¹ß´Þ¼º »ê¼ú Àå¾Ö(º´)(Û¡Ó¹àõ ß©âúî¡äô)
  • developmental articulation disorder
    ¹ß´Þ¼º ±¸À½Àå¾Ö(º´)(Û¡Ó¹àõ Ï¢ëåî¡äô)
  • developmental coordination disorder
    ¹ß´Þ¼º ÇùÀÀÀå¾Ö(º´)(Û¡Ó¹àõ úðëëî¡äô)
  • developmental disorder
    ¹ß´ÞÀå¾Ö(º´)(Û¡Ó¹î¡äô)
  • developmental expressive language disorder
    ¹ß´Þ¼º Ç¥Çö¾ð¾îÀå¾Ö(Û¡Ó¹àõ øúúÞåëåÞî¡äô)(º´)
  • developmental expressive writing disorder
    ¹ß´Þ¼º Ç¥Çö¾²±âÀå¾Ö(Û¡Ó¹àõ øúúÞ~î¡äô)(º´)
  • developmental language disorder
    ¹ß´Þ(¼º) ¾ð¾îÀå¾Ö
  • developmental language disorder
    ¹ß´Þ¼º ¾ð¾îÀå¾Ö(Û¡Ó¹àõ åëåÞî¡äô)(º´)
  • developmental reading disorder
    ¹ß´Þ¼º(Û¡Ó¹àõ) ÀбâÀå¾Ö(º´)(~î¡äô)
  • developmental receptive language disorder
    ¹ß´Þ¼º ¼ö¿ë¾ð¾îÀå¾Ö(º´)(Û¡Ó¹àõ áôé»åëåÞî¡äô)
  • diarrheal disorder
    ¼³»çÁúȯ.
  • disassociative disorder
    ÇØ¸®¼ºÀå¾Ö
  • disorder
    Áúº´(òðÜ»), Àå¾Ö(î¡äô)
  • disorder
    Àå¾Ö(ËøËâ), Áúº´(̤ËÓ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
CPDD calcium pyrophosphate deposition disease; cis-platinum-diamine dichloride
CPPD calcium pyrophosphate dihydrate deposition [syndrome]; cisplatin; cost per patient day
DHPCCB dihydropyridine calcium channel blocker
EFC elastin fragment concentration; endogenous fecal calcium; ephemeral fever of cattle
lo calc low calcium
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
M.D.D. Major Depressive Disorder
M.P.D. Multiple Personality Disorder
MPD Myeloproliferative disorder
NPD Narcissistic personality disorder
OCD Obsessive Compulsive Disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neuropathic pain disorder
    ½Å°æ¼º µ¿Åë Àå¾Ö, ½Å°æº´¼º µ¿Åë Àå¾Ö
  • neuropsychological disorder
    ½Å°æ ½É¸®Àû Àå¾Ö
  • neurotic disorder
    ½Å°æÁõÀû Àå¾Ö
  • neurovascular disorder
    ½Å°æ Ç÷°ü Àå¾Ö
  • non-vascular intracranial disorder
    ºñÇ÷°ü¼º µÎ°³³» Àå¾Ö
  • nonvascular intracranial disorder
    ºñÇ÷°ü¼º µÎ°³³» Àå¾Ö
  • nutritional disorder
    ¿µ¾ç ÀÌ»ó, ¿µ¾ç Àå¾Ö
  • obsessive-compulsive disorder
    °­¹Ú Àå¾Ö
  • order-disorder transformation
    ±ÔÄ¢-ºÒ±ÔÄ¢ º¯ÅÂ
    ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ÀÓÀÇ·Î ¹è¿­Çϰí ÀÖ´Â ºÒ±ÔÄ¢ °ÝÀÚ¿¡¼­ ±ÔÄ¢ ¹Ù¸¥ ¹è¿­ÀÇ ±ÔÄ¢ °ÝÀÚ·Î º¯ÇÏ´Â º¯ÅÂ.
  • organic disorder
    ±âÁú Àå¾Ö
  • orofacial pain disorder
    ±¸°­ ¾È¸é ÅëÁõ Àå¾Ö, ±¸°­ ¾È¸é µ¿Åë Àå¾Ö
  • orthopedic disorder
    Á¤Çü¿Ü°úÀû Àå¾Ö
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • painful muscle disorder
    ÅëÁõ¼º ±ÙÀ° Àå¾Ö
  • pancreatic disorder
    ÃéÀå Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
calcium-binding protein <biochemistry> There are two main groups of calcium binding proteins, those that are similar to calmodulin and are called EF hand proteins and those that bind calcium and phospholipid (e.g. Lipocortin) and that have been grouped under the generic name of annexins.
Many other proteins will bind calcium, although the binding site usually has considerable homology with the calcium-binding domains of calmodulin. They can act as transport proteins, regulator proteins or activator proteins.
There is also a vitamin D-dependent variant which is a protein that plays a fundamental role in the vitamin d mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent.
(12 May 2002)
calcium bromide Used to meet the same indications as potassium bromide.
(05 Mar 2000)
calcium-calmodulin-activated histone 3 arginine kinase <enzyme> From nuclear extracts of dividing and quiescent rat heart endothelial cells; represents a new class of ca-cam-dependent kinases which phosphorylate arg
Registry number: EC 2.7.10.-
Synonym: ca(2+)-calmodulin-activated histone 3 arg kinase, ca-cam h3 kinase
(26 Jun 1999)
calcium-calmodulin-dependent phosphodiesterase <enzyme> Hydrolyzes both cgmp and camp; induced during mitogenesis
Registry number: EC 3.1.4.-
Synonym: ca-cam-phosphodiesterase, calmodulin-dependent cgmp phosphodiesterase
(26 Jun 1999)
calcium-calmodulin dependent protein kinase <enzyme> A calmodulin-dependent enzyme that catalyses the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins.
Registry number: EC 2.7.10.-
(12 Dec 1998)
calcium carbide CaC2;blackish crystalline lumps which when in contact with water yield acetylene gas.
(05 Mar 2000)
calcium carbimide <drug> This drug is used to treat alcoholism, if a person takes this drug and then drinks any alcohol at all, they will get sick (headache, nausea, vertigo, etc.)
(09 Oct 1997)
calcium carbonate An astringent, an antacid
(27 Sep 1997)
calcium caseinate The form of casein present in cow's milk; used in dietetic preparations; has been used for diarrhoea in infants.
(05 Mar 2000)
calcium channel <physiology> A membrane channel that is specific for calcium. It is a voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorised as l, t, n, or p types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins.
(12 May 2002)
calcium channel agonist <pharmacology> Agents that increase calcium influx into calcium channels of excitable tissues.
This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.
(12 Dec 1998)
calcium channel antagonist <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
calcium channel-blocker <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
calcium chloride <chemical> Calcium chloride (cacl2). A salt that occurs as white, hard fragments or granules. It is used as a calcium replenisher, administered intravenously, has been used as an acid-producing diuretic and urinary acidifier and to control bleeding in such conditions as purpura, intestinal bleeding, and small multiple haemorrhages. It is also a specific antidote for magnesium poisoning, administered intravenously.
Chemical name: Calcium chloride (CaCl2)
(12 Dec 1998)
calcium citrate <chemical> A colourless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent.
Pharmacological action: antioxidants.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á